Organizing Committee Member
Vladimir P. Torchilin
Director and Professor
Northeastern University
USA
Biography
Vladimir P. Torchilin, Ph.D., D.Sc. is a University Distinguished Professor of Pharmaceutical Sciences and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy. He has published more than 400 original papers, more than 150 reviews and book chapters, wrote and edited 12 books, and holds more than 40 patents. Google Scholar shows more than 52,000 citations of his papers with H-index of 102. He is Editor-in-Chief of Current Drug Discovery Technologies, Drug Delivery, and OpenNano, Co-Editor of Current Pharmaceutical Biotechnology and on the Editorial Boards of many other journals. Among his many awards, Professor Torchilin was the recipient of the 1982 Lenin Prize in Science and Technology (the highest scientific award in the former USSR). He was elected as a Full Member of the European Academy of Sciences. He is also a Fellow of American Association of Pharmaceutical Scientists (AAPS), American Institute of Medical and Biological Engineering, and Controlled Release Society (CRS). In 2005 he received the Research Achievements Award in Pharmaceutics and Drug Delivery from the AAPS; in 2006 – the 2006 CRS-Baxter Healthcare Outstanding Parenteral Drug Delivery Award; in 2007 – the Research Achievements Award from the World Pharmaceutical Congress. He got also 2009 AAPS Journal Award, 2009 International Journal of Nanomedicine Distinguished Scientist Award, 2010 Controlled Release Society Founders Award, 2012 Alec Bangham Life Time Achievements Award, and 2013 Blaise Pascal Medal in Biotechnology from the European Academy of Sciences. He served as a President of the Controlled Release Society in 2005/2006 and is on the Board of Directors of the International Liposome Society. He received more than $30 M from the governmental and industrial sources in research funding. In 2011, Times Higher Education ranked him number 2 among top world scientists in pharmacology for the period of 2000-2010.
Research Area
His interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy.